Potential 18F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy

Potential 18F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy

PurposeTo investigate the ability of potential imaging biomarkers based on 18F-AlF-NOTA-PRGD2 positron emission tomography/computed tomography (18F-RGD PET/CT) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) imaging to predict the response to bevacizumab combined with conventional...

Full description

Bibliographic Details
Main Authors: Li Li, Ning Liu, Hui Zhang, Rongjie Tao, Shuqiang Zhao, Zhaoqiu Chen, Zheng Fu, Wanhu Li, Liang Xu, Yuhui Liu, Jinming Yu, Shuanghu Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Glioblastoma
18F-RGD PET/CT
DCE-MRI
bevacizumab
concurrent radiotherapy and temozolomide
PFS
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.848266/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.848266/full

Similar Items